Skip to main
GEHC

GEHC Stock Forecast & Price Target

GEHC Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 21%
Buy 29%
Hold 43%
Sell 0%
Strong Sell 7%

Bulls say

GE HealthCare Techs is a leading medical technology firm with a diverse sales portfolio and a strong presence in key global markets. The company has shown consistent revenue growth and has a positive outlook for the future, driven by factors such as a healthy US capital equipment environment, potential for growth in radiopharmaceuticals, and the reduced risk of GE selling its shares. While trade-war and inflationary impacts may have affected the company in the near term, GEHC's strong operational performance and ability to adapt to changing market dynamics suggest it is well-positioned for long-term success.

Bears say

GE HealthCare Techs is facing several challenges that could negatively impact its stock, including margin pressures from inflation and tariffs as well as slowing revenue growth. While the company is investing in new products and markets, it still faces competition from other healthcare technology firms. Additionally, its heavy reliance on the financial health of its clients makes it vulnerable to any slowdown in clinical trial activity or R&D investments. While there is potential for upside, particularly with the recovery of the biopharma industry, risks remain, including potential security breaches and declines in demand for its solutions.

GEHC has been analyzed by 14 analysts, with a consensus rating of Buy. 21% of analysts recommend a Strong Buy, 29% recommend Buy, 43% suggest Holding, 0% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GE HealthCare Technologies Inc (GEHC) Forecast

Analysts have given GEHC a Buy based on their latest research and market trends.

According to 14 analysts, GEHC has a Buy consensus rating as of May 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $81.64, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $81.64, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GE HealthCare Technologies Inc (GEHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.